My Account

Friday, December 27, 2024

Canada’s Politics and Government News Source Since 1989

With renewed investment in diabetes research, Canada can be home to the next breakthrough again

We have seen what is possible when researchers come together with a singular goal through the development of several COVID-19 vaccines in record time, demonstrating that co-ordinated efforts plus investment leads to accelerated results that save lives.

Opinion
BY DAVE PROWTEN
February 11, 2021

Opinion | BY DAVE PROWTEN | February 11, 2021

FOLLOW THE HILL TIMES:

Want to make sure your whole office has the full Hill Times experience?

We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.

More Opinion

Canada must lead the fight against plastic pollution

OpinionBY JOSH LAUGHREN

Canadian horses’ suffering continues beyond anniversary of ministerial mandate letter

OpinionBY KAITLYN MITCHELL

The long-term health toll of Canada’s opioid crisis

OpinionBY MYANCA RODRIGUE, BRITTANY B. DENNIS, ZAINAB SAMAAN

A paradigm shift is needed on Canada’s approach to international humanitarian aid

OpinionBY NISHA TOOMEY, ISABELLA AUNG, MEHEK BERRY, SAMANTHA MCGAVIN

There’s even greater urgency in building a stronger economy

OpinionBY DAVID CRANE

Can biotechnology put patients’ needs ahead of profits?

OpinionBY SHARON BATT

There are no overnight successes in science: medical research needs more stable funding

OpinionBY MICHAEL SEFTON

Can biotechnology put patients’ needs ahead of profits?

OpinionBY SHARON BATT

These are challenging dilemmas for a government that gutted a suite of policies designed to cap excessive drug prices, and that 'waxed lyrical' about the importance of accelerating vaccine access worldwide, then failed to support an intellectual property waiver that would expand global production of COVID-19 vaccines.

Can biotechnology put patients’ needs ahead of profits?

OpinionBY SHARON BATT

These are challenging dilemmas for a government that gutted a suite of policies designed to cap excessive drug prices, and that 'waxed lyrical' about the importance of accelerating vaccine access worldwide, then failed to support an intellectual property waiver that would expand global production of COVID-19 vaccines.

There are no overnight successes in science: medical research needs more stable funding

OpinionBY MICHAEL SEFTON

There are no overnight successes in science: medical research needs more stable funding

OpinionBY MICHAEL SEFTON

On June 21, 2021, the Senate adopted unanimously Bill C-237 for a National Framework on Diabetes. My expertise with diabetic foot in senior health care had motivated me to sponsor Liberal MP Sonia Sidhu’s, pictured, bill. Since the beginning of the pandemic, studies have shown that diabetes is one of the major comorbidities associated with the development of severe COVID-19-related adverse outcomes and mortality. A new hypothesis is linking COVID-19 to the development of diabetes. The Hill Times photograph by Cynthia Münster

On the road to a better control of the diabetes epidemic in Canada

OpinionBY ISG SENATOR MARIE-FRANçOISE MéGIE

On the road to a better control of the diabetes epidemic in Canada

OpinionBY ISG SENATOR MARIE-FRANçOISE MéGIE

A ‘once-in-a-generation’ chance to reset vaccine innovation in Canada

OpinionBY MATTHEW HERDER AND SRINIVAS MURTHY

A ‘once-in-a-generation’ chance to reset vaccine innovation in Canada

OpinionBY MATTHEW HERDER AND SRINIVAS MURTHY

Diabetes and COVID-19

OpinionBY LIBERAL MP SONIA SIDHU

Diabetes and COVID-19

OpinionBY LIBERAL MP SONIA SIDHU

With renewed investment in diabetes research, Canada can be home to the next breakthrough again

We have seen what is possible when researchers come together with a singular goal through the development of several COVID-19 vaccines in record time, demonstrating that co-ordinated efforts plus investment leads to accelerated results that save lives.

Canada must lead the fight against plastic pollution

Canadian horses’ suffering continues beyond anniversary of ministerial mandate letter

The long-term health toll of Canada’s opioid crisis

A paradigm shift is needed on Canada’s approach to international humanitarian aid

There’s even greater urgency in building a stronger economy

Can biotechnology put patients’ needs ahead of profits?

There are no overnight successes in science: medical research needs more stable funding

On the road to a better control of the diabetes epidemic in Canada

A ‘once-in-a-generation’ chance to reset vaccine innovation in Canada

Diabetes and COVID-19

Can biotechnology put patients’ needs ahead of profits?

Can biotechnology put patients’ needs ahead of profits?

There are no overnight successes in science: medical research needs more stable funding

There are no overnight successes in science: medical research needs more stable funding

On the road to a better control of the diabetes epidemic in Canada

On the road to a better control of the diabetes epidemic in Canada

A ‘once-in-a-generation’ chance to reset vaccine innovation in Canada

A ‘once-in-a-generation’ chance to reset vaccine innovation in Canada

Diabetes and COVID-19

Diabetes and COVID-19

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Follow us

Advertise

subscribe

get help

Get free news updates

Submit a guest opinion article

With renewed investment in diabetes research, Canada can be home to the next breakthrough again

We have seen what is possible when researchers come together with a singular goal through the development of several COVID-19 vaccines in record time, demonstrating that co-ordinated efforts plus investment leads to accelerated results that save lives.

Get The Weekend Point of View Newsletter